Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Sustainability
The Rise of ESG: Where It Is Now and How It Got Here
Calls for corporate reform are as old as the corporation itself, so why now are companies pushing for more ESG efforts in their organizations?
By
Ted Jackson
| July 5, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Novartis
Risk & Compliance
Novartis Settles U.S. Bribery Charges
The pharma giant will pay more than $346 million to settle charges that it bribed doctors to prescribe their drugs.
By
Lauren Muskett
| June 26, 2020
Read More
Strategy
Novartis to Buy AveXis in $8B Gene Therapy Bet
The deal gives the Swiss drugmaker a neurological disease treatment that may have "a multi-billion dollar peak sales potential."
By
Matthew Heller
| April 9, 2018
Read More
Strategy
GSK Buys Novartis out of Joint Venture for $13B
The acquisition of Novartis' stake will give GSK full control over the revenues from such products as Sensodyne toothpaste and the Excedrin pain reliever.
By
Matthew Heller
| March 27, 2018
Read More
Human Capital & Careers
Specialty Drug Costs to Soar Again in 2018
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
By
David McCann
| September 22, 2017
Read More
Risk & Compliance
Novartis Settles Kickback Charges for $370M
The Swiss drug maker allegedly turned specialty pharmacies into a "biased sales force" for its medications.
By
Matthew Heller
| November 20, 2015
Read More
Profiles
CFO Snapshot: Sweating in Front of the Board
Meryl Zausner, the U.S. finance chief of Novartis, shares her thoughts on the CFO role and the path she took to get there.
By
Kate O'Sullivan
| July 27, 2012
Read More
People
Risk Takers, Career Makers
How are women making it to the top in finance? Sometimes by making unconventional, even risky, career moves.
By
Alix Stuart
| May 15, 2012
Read More